Updates

T Clarke

August 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Interims from T Clarke have seen it raise its revenue guidance for the full year to £450m versus the previous £410m.As it was, the H1 results this month showed sales up 49% to £206m and pretax profit almost tripled from £1.9m to £5.5m with eps up from 3.6p to 10.2p.The growth in revenues was mostly driven by the London business and its data centre fitout operations. After deducting group costs of £2m, operating margin improved from 1.7% to 2.9%. Net cash improved to £7.2m. Assuming a slightly higher tax charge, eps has been upgraded modestly to 21.4p. With the order book at another record of £586m at end June (+10% on Dec-21), this fully secures this year’s forecast and has covered two thirds of next year’s. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Strix

Ergomed - Well set for an eps ‘beat’

TClarke - 160p cash offer from Regent Gas (May 2024)

TClarke (April 2024)

TClarke (August 2023)

TClarke (June 2023)

T Clarke (February 2023)

T Clarke (December 2022)

T Clarke - High confidence to beat forecasts (June 2022)

T Clarke - Eps of 21.1p forecast this year (April 2022)

T Clarke - Record Q4 for sales and no supply chain issues (December 2021)

T Clarke - Data centre wins balloon order book to £503m (September 2021)

T Clarke - Cash adjusted PE of 4.7 (February 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X